Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Jasmate** is a topical herbal and mineral-containing dentifrice developed by Jasberry Healthcare for reduction of dentinal hypersensitivity and use following periodontal treatment. The formulation reported in clinical-trial materials contains potassium nitrate, sodium fluoride, hydroxyapatite, arginine hydrochloride, calcium carbonate, zinc oxide, and multiple botanical ingredients. Its intended desensitizing action is primarily physical occlusion of exposed dentinal tubules, with fluoride and hydroxyapatite intended to support mineral deposition and potassium nitrate contributing to dentinal desensitization. Jasmate Toothpaste received US FDA 510(k) substantial-equivalence clearance as a Class II dental device under K242913. ([accessdata.fda.gov](https://www.accessdata.fda.gov/cdrh_docs/pdf24/K242913.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jasmate.